Home / News
-
-
Illumina said on Tuesday that it has received CE-IVD marking for its TruSight Oncology Comprehensive (EU) assay this month.2022-03-16View More
-
-
Burning Rock Biotech said on Tuesday that the National Medical Products Administration of China has approved its nine-gene sequencing assay, LungCure CDx, as a Class III medical device.2022-03-16View More
-
-
The development of new scientific ways to see more deeply into the building blocks of nature on a cellular level has led to the some of the greatest advances in medicine over the last century.2022-03-15View More
-
-
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will invest $97 million to expand its clinical research operations in Richmond, Virginia.2022-03-15View More
-
-
Jilin Province has ordered 12 million antigen detection reagents nationwide in a short period of time, some have been delivered.2022-03-15View More
-
-
Recently, the domestic epidemic situation is severe, and the release of the "Plan" further optimizes the COVID-19 detection strategy to serve the needs of epidemic prevention and control.2022-03-14View More
-
-
Thermo Fisher Scientific has released the Invitrogen SuperScript IV RT-LAMP Master Mix for the fast and sensitive detection of viral pathogens, including SARS-CoV-2, measles, and influenza.2022-03-14View More
-
-
Lucira Health on Thursday reported a huge year-over-year surge in revenues for the fourth quarter of 2021 on ramped-up manufacture and sale of the company's molecular at-home COVID-19 tests.2022-03-14View More
-
-
Cancer detection is a major public health challenge, and the methods currently available to achieve it, for example MRIs and mammograms, are often expensive and invasive.2022-03-11View More
-
-
Oncocyte Corporation reported after the close of market Thursday that its fourth quarter and 2021 revenues rose sevenfold and sixfold, respectively, over their prior-year periods.2022-03-11View More
-
-
Medix Biochemica is launching a rejuvenated brand to reflect both the exciting improvements to its offering as a result of recent acquisitions, and its ongoing commitment to the in vitro diagnostics (IVD) industry.2022-03-11View More
-
-
On March 9, Autobio released a performance report. The company's sales revenue from January to December 2021 was CNY 3.767 billion , a year-on-year increase of 26.48%.2022-03-10View More
-
-
Roche Diagnostics has launched its new molecular laboratory instrument, the cobas 5800 System, in the UK. Through improved automation, the new system can help raise testing volumes, improve operational efficiency, and manage the increasing demand that many laboratories are experiencing, Roche said.2022-03-10View More
-
-
Canadian firm MedMira said Wednesday it has obtained the CE mark for its Reveal TP (Syphilis) test, making it available in the European Union as well as other geographies that accept the designation.2022-03-10View More
-
-
Zhenzhun Biotechnology (Shanghai) Co. Ltd., a digital PCR company, has recently completed a Series A financing round of over CNY 100 million, exclusively invested by Huiyuan Capital, a professional investment institution in the healthcare industry.2022-03-09View More
-
-
A review of adverse events following vaccination against COVID-19 with mRNA vaccines in the USA confirms that most side effects were mild and decreased substantially after one day.2022-03-09View More
-
-
Luminex, a DiaSorin company, said on Tuesday that it has received CE marking for its xMap NxTag Gastrointestinal Pathogen Panel (GPP), a molecular multiplex panel for the detection of 16 different pathogens.2022-03-09View More
-
-
A new viral transport medium that enables collection and rapid inactivation of the SARS-CoV-2 virus, and stabilizes viral RNA at ambient temperature for transportation and use in in vitro diagnostic testing procedures, is now available in Europe.2022-03-08View More
-
-
Chinese single-cell technology firm Singleron Biotechnologies said on Monday that it has acquired Singapore-based Proteona.2022-03-08View More
-
-
The updated prospectus shows that Adicon additionally disclosed financial data for 2021 and other content. According to the prospectus, Adicon's operating income in 2021 will be CNY 3.380 billion.2022-03-08View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.